Recombinant trivalent influenza vaccine (Jiangsu Recbio Technology)
重组三价流感疫苗（江苏瑞科生物）
Report date: 2026/04/03 20:03:44
Base Information
Drug NameRecombinant trivalent influenza vaccine (Jiangsu Recbio Technology)
Drug Alias Name
Classification +[4]
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJiangsu Rec-Biotechnology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesJiangsu Rec-Biotechnology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A